Perioperative and long-term risks following nephrectomy in older live kidney donors
Perioperative and long-term risks following nephrectomy in older live kidney donors
批准号:
10547777
负责人:
Abimereki D Muzaale
金额:
$17.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-12-31
关键词:
AffectAgeAgingBiological MarkersCardiovascular DiseasesCharacteristicsClinicalCodeCognitiveContrast MediaDataData SetDiabetes MellitusDiagnosisDiagnostic ProcedureDoctor of PhilosophyDrug PrescriptionsElderlyEnd stage renal failureEnrollmentEventFacultyFractureFundingGeneral PopulationGoalsGrantGuidelinesHealthHospitalizationHypertensionIncidenceIndividualInformation SciencesInpatientsInvestigationKidneyKidney DiseasesKidney TransplantationKnowledgeLaboratoriesLearningLightLinkLogistic RegressionsMedicalMentorshipMineralsMulticenter StudiesNational Health and Nutrition Examination SurveyNephrectomyNephronsOlder PopulationOperative Surgical ProceduresOrgan TransplantationOutcomePatientsPerioperativePersonal SatisfactionPharmaceutical PreparationsPilot ProjectsPopulationPostdoctoral FellowPractice GuidelinesPredispositionPrevalencePrincipal InvestigatorProviderPublishingQuality of lifeResearchResourcesRiskSamplingScienceSentinelSourceSpecific qualifier valueStressSystemTestingTrainingTransplantationUniversitiesWorkadverse outcomeage relatedagedaging populationattributable mortalitybone metabolismcare providerscareerclinical investigationclinical phenotypecohortdata registrydesigndisabilityepidemiology studyfunctional outcomeshigh riskimprovedlearning strategyliving kidney donormortalitymortality risknovelpredictive toolsprogramsresilienceresponsesenescencetrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The number of older adults (aged≥55) undergoing live donor nephrectomy has quadrupled over the last two
decades and this trend is likely to continue. However, a knowledge gap exists in our understanding of the
resiliencies to physical stress in older donors. Beyond age-related vulnerability to surgical stress, this aging
population may have significant glomerular senescence, an inadequate adaptive response to the 50% loss of
nephron mass and, as such, a very high likelihood of CKD in their lifetime. Approximately 80% of older donors
have a postdonation GFR<60 ml/min/1.73m2 and meet the standard definition of CKD. As older donors
progress towards CKD, they are likely to become frail and, as such, at increased risk of hospitalization.
No study has focused on the identification of clinical signatures of resiliency in older persons undergoing live
donor nephrectomy. The renal system is directly impacted by nephrectomy and its resiliency may affect the
health and well-being of older donors. Provider discussions with these potential donors should focus on the
patient's most important question: “Can I safely donate my kidney?” not the population-level question asked by
the 2017 KDIGO guidelines: “How many ESRD events in younger donors may be averted by transplanting
older donors instead?”
We propose the following scientific aims: 1. To quantify donation-attributable risk of ESRD and mortality in
older donors; 2. To describe the prevalence of hospitalizations in older donors vs. older nondonors; and 3. To
implement a risk calculator for ESRD, mortality and sentinel hospitalization in older donors.
A detailed training plan for Abimereki Muzaale, MD, MPH is outlined in this proposal. In brief, it includes
enrollment in the PhD in Clinical Investigation Program at The Johns Hopkins University, in-depth course work
in aging research, and a mentorship plan jointly prepared by the principal investigator and a team with
expertise in kidney disease, aging research, information sciences, and the mentorship of junior faculty. This
team will help the candidate meet the following career goals: (1) Receive formal training in aging research; (2)
Apply for and obtain R01 grant funding; and (3) Transition to independence.
Our efforts will culminate in the creation of online risk calculators that inform the conversation between
candidates and providers about the propriety of donation. Dr. Muzaale will learn how sentinel hospitalization
events in an aging cohort of older donors leave a footprint of present and missing data that will be methodically
crucial in preparing an R01 proposal to characterize trajectories of resiliency from laboratory, physical,
cognitive, and other tests.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Perioperative and long-term risks following nephrectomy in older live kidney donors
-
批准号:10348207
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2020
-
负责人:Abimereki D Muzaale
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: